Bausch + Lomb Corporation (BLCO)

USD 18.24

(-3.24%)

Revenue Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual revenue in 2023 was 4.14 Billion USD , up 10.03% from previous year.
  • Bausch + Lomb Corporation's latest quarterly revenue in 2024 Q3 was 1.19 Billion USD , down -1.64% from previous quarter.
  • Bausch + Lomb Corporation reported a annual revenue of 3.76 Billion USD in annual revenue 2022, up 0.08% from previous year.
  • Bausch + Lomb Corporation reported a annual revenue of 3.76 Billion USD in annual revenue 2021, up 10.35% from previous year.
  • Bausch + Lomb Corporation reported a quarterly revenue of 1.09 Billion USD for 2024 Q1, down -6.31% from previous quarter.
  • Bausch + Lomb Corporation reported a quarterly revenue of 1.21 Billion USD for 2024 Q2, up 10.65% from previous quarter.

Annual Revenue Chart of Bausch + Lomb Corporation (2023 - 2018)

Historical Annual Revenue of Bausch + Lomb Corporation (2023 - 2018)

Year Revenue Revenue Growth
2023 4.14 Billion USD 10.03%
2022 3.76 Billion USD 0.08%
2021 3.76 Billion USD 10.35%
2020 3.41 Billion USD -9.69%
2019 3.77 Billion USD 3.08%
2018 3.66 Billion USD 0.0%

Peer Revenue Comparison of Bausch + Lomb Corporation

Name Revenue Revenue Difference
Alcon Inc. 10.09 Billion USD 58.918%
AptarGroup, Inc. 3.48 Billion USD -18.883%
Baxter International Inc. 14.81 Billion USD 72.011%
Becton, Dickinson and Company 20.17 Billion USD 79.453%
Haemonetics Corporation 1.3 Billion USD -216.717%
Envista Holdings Corp 2.56 Billion USD -61.543%
ResMed Inc. 4.68 Billion USD 11.51%
Teleflex Incorporated 2.97 Billion USD -39.385%
Warby Parker Inc. 669.76 Million USD -519.023%
West Pharmaceutical Services, Inc. 2.94 Billion USD -40.552%